Niche Market Focus JayMac Pharmaceuticals specializes in FDA-regulated folate therapies targeting psychiatric and obstetric markets, presenting opportunities to connect with healthcare providers in mental health and women's health sectors seeking innovative treatment options.

Strong Product Demand The company's flagship products, EnLyte and EnBrace HR, have maintained steady demand due to their unique, proprietary formulations, indicating potential for expansion within existing specialty areas and related hospital systems.

Innovative Business Model With a hybrid sales force and a talented inside sales team, there is potential to offer tailored sales solutions that enhance outreach and strengthen relationships with specialty clinics, hospitals, and healthcare networks.

Technological Infrastructure Utilizing cloud-based and modern web technologies, JayMac Pharmaceuticals presents opportunities for digital engagement strategies, including targeted online marketing and virtual detailing to healthcare professionals.

Financial Growth Potential Operating with revenues between $1M and $10M, the company shows growth potential that can be supported through strategic partnerships, licensing arrangements, or expansion into additional specialty therapeutic areas.